StockScreener

Stocks ETFs Institutions People Radar Earnings

News Narratives

Signals Market Market Map Performance

Stocks ETFs Institutions People Radar Earnings

News Narratives

Signals Market Market Map Performance

Redmile Biopharma Investments II, L.P.

CIK 1772230 · View on SEC EDGAR ↗

Activist

First SEC filing: June 11, 2026 · Latest: June 11, 2026

StockScreener

Stock analysis and trading signals for NASDAQ.

Navigate

Stocks ETFs Institutions People Radar Earnings News Signals

Resources

News Narratives Methodology Telegram

Legal

About Author Privacy Policy Terms of Service Disclaimer Editorial Policy

This is not financial advice. All information is provided for educational and informational purposes only.

© 2025-2026 StockScreener

We use cookies to analyze site traffic and improve your experience. Learn more

Cookie preferences

Necessary Essential for basic site functions: language, theme, consent memory.

Analytics Help us understand how visitors use the site. Anonymous traffic data.

Marketing Measure ad effectiveness and show relevant ads. Google Ads cookies.

Personalization Personalized content and ad recommendations based on your browsing.